3 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 3 of 3 clinical reviews.
Find out whether Medicare Advantage plans cover PT-141 (bremelanotide/Vyleesi), what you can expect to pay, and how to access this medication affordably through compounding pharmacies, manufacturer programs, and alternative coverage pathways.
Medicare Part D does not cover PT-141 (bremelanotide/Vyleesi) for hypoactive sexual desire disorder. Learn why, what it costs out of pocket, and how to access it affordably through compounding pharmacies, manufacturer programs, and alternative coverage routes.
How to access PT-141 (bremelanotide) at reduced or no cost through manufacturer programs, compounding pharmacies, and patient assistance options in 2026.